These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 24275570)

  • 61. Agitation and psychosis in dementia.
    Ballard C
    Am J Geriatr Psychiatry; 2007 Nov; 15(11):913-7. PubMed ID: 17974863
    [No Abstract]   [Full Text] [Related]  

  • 62. [Haloperidol and promethazine in psychotic aggression].
    Jürgens G; Bauer JØ
    Ugeskr Laeger; 2017 Apr; 179(16):. PubMed ID: 28416057
    [No Abstract]   [Full Text] [Related]  

  • 63. Emergency treatment of acute psychosis, agitation, and anxiety.
    Ellison JM
    Hosp Community Psychiatry; 1985 Apr; 36(4):351-2. PubMed ID: 3997094
    [No Abstract]   [Full Text] [Related]  

  • 64. Duration of risperidone treatment for BPSD.
    Snowdon J; Brodaty H; Ames D; Day S
    Int J Geriatr Psychiatry; 2006 Jul; 21(7):699-701. PubMed ID: 16821255
    [No Abstract]   [Full Text] [Related]  

  • 65. Psychotic symptoms, aggression and restlessness in dementia.
    Ballard C; Gray A; Ayre G
    Rev Neurol (Paris); 1999; 155 Suppl 4():S44-52. PubMed ID: 10637938
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Rapid Tranquilization for Psychiatric Patients with Psychomotor Agitation: What is Known About it?
    de Almeida CG; Del Grossi Moura M; Barberato-Filho S; de Sá Del Fiol F; Motta RHL; de Cássia Bergamaschi C
    Psychiatr Q; 2017 Dec; 88(4):885-895. PubMed ID: 28275892
    [TBL] [Abstract][Full Text] [Related]  

  • 67. A naturalistic study of intramuscular haloperidol versus intramuscular olanzapine for the management of acute agitation.
    MacDonald K; Wilson M; Minassian A; Vilke GM; Becker O; Tallian K; Cobb P; Perez R; Galangue B; Feifel D
    J Clin Psychopharmacol; 2012 Jun; 32(3):317-22. PubMed ID: 22544013
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The effectiveness of atypical antipsychotics for the treatment of aggression and psychosis in Alzheimer's disease.
    Ballard C; Waite J
    Cochrane Database Syst Rev; 2006 Jan; 2006(1):CD003476. PubMed ID: 16437455
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Comparison of intramuscular olanzapine, orally disintegrating olanzapine tablets, oral risperidone solution, and intramuscular haloperidol in the management of acute agitation in an acute care psychiatric ward in Taiwan.
    Hsu WY; Huang SS; Lee BS; Chiu NY
    J Clin Psychopharmacol; 2010 Jun; 30(3):230-4. PubMed ID: 20473056
    [TBL] [Abstract][Full Text] [Related]  

  • 70. A double-blind comparison of trazodone and haloperidol for treatment of agitation in patients with dementia.
    Sultzer DL; Gray KF; Gunay I; Berisford MA; Mahler ME
    Am J Geriatr Psychiatry; 1997; 5(1):60-9. PubMed ID: 9169246
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The efficacy of a rapid-acting intramuscular formulation of olanzapine for positive symptoms.
    Jones B; Taylor CC; Meehan K
    J Clin Psychiatry; 2001; 62 Suppl 2():22-4. PubMed ID: 11232747
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Paradoxical severe agitation induced by add-on high-doses quetiapine in schizo-affective disorder.
    Fond G; MacGregor A; Ducasse D; Brittner M
    Psychiatry Res; 2014 May; 216(2):286-7. PubMed ID: 24582773
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Droperidol vs. haloperidol in the initial management of acutely agitated patients.
    Resnick M; Burton BT
    J Clin Psychiatry; 1984 Jul; 45(7):298-9. PubMed ID: 6376480
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Effectiveness of Intramuscular Chlorpromazine for Rapid Treatment of Psychomotor Agitation: A Naturalistic, Retrospective, and Observational Study.
    Cuomo A; Chioccioli M; Cattaneo CI; Magnani PA; Bussolotti D; Larcinese R; Bruni A; Torti C; Fagiolini A
    J Clin Psychopharmacol; 2021 Sep-Oct 01; 41(5):613-614. PubMed ID: 34155163
    [No Abstract]   [Full Text] [Related]  

  • 75. Is relapse a justification for the use of high-dose antipsychotics?
    Cohen S; Chiles JA
    J Clin Psychiatry; 1990 Nov; 51(11):486-7. PubMed ID: 1977741
    [No Abstract]   [Full Text] [Related]  

  • 76. Pharmacological treatment of psychosis and agitation in elderly patients with dementia: four decades of experience.
    Kindermann SS; Dolder CR; Bailey A; Katz IR; Jeste DV
    Drugs Aging; 2002; 19(4):257-76. PubMed ID: 12038878
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Droperidol v. haloperidol for sedation of aggressive behaviour in acute mental health: randomised controlled trial.
    Calver L; Drinkwater V; Gupta R; Page CB; Isbister GK
    Br J Psychiatry; 2015 Mar; 206(3):223-8. PubMed ID: 25395689
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Antipsychotic Selection for Acute Agitation and Time to Repeat Use in a Psychiatric Emergency Department.
    Gomez S; Dopheide J
    J Psychiatr Pract; 2016 Nov; 22(6):450-458. PubMed ID: 27824777
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Clinical and therapeutic aspects of agitation].
    San L
    Encephale; 2007 Jun; 33 Pt 3():S375-9. PubMed ID: 19101354
    [No Abstract]   [Full Text] [Related]  

  • 80. Very low-dose neuroleptic treatment in two patients with agitation associated with Alzheimer's disease.
    Risse SC; Lampe TH; Cubberley L
    J Clin Psychiatry; 1987 May; 48(5):207-8. PubMed ID: 2883174
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.